Equipped with advanced capabilities, the Mitsubishi generator series is built to meet the demanding needs of the Australian ...

The MCU’s Phase 4 released instalments during 2021 and ’22, Phase 5 released during 2023, ’24, and ’25, and Phase 6 will run until 2027. Following this pattern, the MCU’s Phase 7 will likely span ...

PLYMOUTH MEETING, Pa., September 24, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the ...

The Andhra Pradesh State Council of Higher Education (APSCHE) has released the AP EAMCET 2025 phase 3 and final seat allotment results at eapcet-sche.aptonline.in. Candidates must download their ...

CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...

When upgrading Flutter SDK to 3.35.1 (Dart 3.9.0), we are getting dependency resolution issues because hive_generator is pinned to outdated tooling. build_runner ^2.7.0 → needs build ^3.x freezed/json ...

Treatment with AD109 resulted in a clinically meaningful and statistically significant reduction in airway obstruction compared with placebo. Topline results were announced from a second phase 3 trial ...

A hybrid phase demodulation structure combining a 3 × 3 coupler and Sagnac interferometer is proposed to improve the spatial resolution and phase demodulation performance of the phase-sensitive ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The mRNA shot stacked up well against a licensed ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with pulmonary arterial hypertension (PAH) has completed enrollment. The ADVANCE OUTCOMES trial (NCT03626688) ...